Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders  by Hasselbacher, K. et al.
see commentary on page 980
Recessive missense mutations in LAMB2 expand the
clinical spectrum of LAMB2-associated disorders
K Hasselbacher1,2, RC Wiggins3, V Matejas4, BG Hinkes1, B Mucha1, BE Hoskins1, F Ozaltin1,5, G Nu¨rnberg6,
C Becker6, D Hangan1, M Pohl7, E Kuwertz-Bro¨king8, M Griebel9, V Schumacher10, B Royer-Pokora10,
A Bakkaloglu5, P Nu¨rnberg6, M Zenker4 and F Hildebrandt1
1Departments of Pediatrics and of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA; 2Division of Nephrology,
University of Erlangen-Nuremberg, Erlangen-Nuremberg, Germany; 3Department of Internal Medicine, University of Michigan, Ann
Arbor, Michigan, USA; 4Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen-Nuremberg, Germany; 5Department of
Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey; 6Cologne Center for Genomics (CCG) and Institute for
Genetics, University of Cologne, Cologne, Germany; 7Department of Pediatric and Adolescent Medicine, University of Freiburg, Freiburg,
Germany; 8Department of Pediatric Nephrology, University of Muenster, Muenster, Germany; 9Department of Pediatric Nephrology,
Technical University of Munich, Munich, Germany and 10Institute of Human Genetics, University of Duesseldorf, Duesseldorf, Germany
Congenital nephrotic syndrome is clinically and genetically
heterogeneous. The majority of cases can be attributed to
mutations in the genes NPHS1, NPHS2, and WT1. By
homozygosity mapping in a consanguineous family with
isolated congenital nephrotic syndrome, we identified a
potential candidate region on chromosome 3p. The LAMB2
gene, which was recently reported as mutated in Pierson
syndrome (microcoria-congenital nephrosis syndrome; OMIM
#609049), was located in the linkage interval. Sequencing of all
coding exons of LAMB2 revealed a novel homozygous missense
mutation (R246Q) in both affected children. A different mutation
at this codon (R246W), which is highly conserved through
evolution, has recently been reported as causing Pierson
syndrome. Subsequent LAMB2 mutational screening in six
additional families with congenital nephrotic syndrome revealed
compound heterozygosity for two novel missense mutations in
one family with additional nonspecific ocular anomalies. These
findings demonstrate that the spectrum of LAMB2-associated
disorders is broader than previously anticipated and includes
congenital nephrotic syndrome without eye anomalies or with
minor ocular changes different from those observed in Pierson
syndrome. This phenotypic variability likely reflects specific
genotypes. We conclude that mutational analysis in LAMB2
should be considered in congenital nephrotic syndrome, if no
mutations are found in NPHS1, NPHS2, or WT1.
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Congenital nephrotic syndrome is a heterogeneous disorder
characterized by proteinuria with consecutive edema starting
in utero or within the first 3 months of life.1 NPHS1 and
NPHS2 mutations are known to be associated with
autosomal recessive isolated nephrosis.2,3 The respective gene
products nephrin and podocin are interacting transmem-
brane proteins at the glomerular slit diaphragm.4,5 Specific
heterozygous mutations in WT1, a zinc-finger transcription
factor, can cause Denys–Drash syndrome, Frasier syndrome,
or isolated diffuse mesangial sclerosis.6 We have recently
shown in a worldwide cohort of 48 patients with nephrotic
syndrome within the first year of life that mutations in
NPHS1, NPHS2, and WT1 account for 44, 44, and 5% of
cases, respectively.7 Still, in some cases with isolated
congenital nephrotic syndrome and in the majority of
patients with syndromic forms associated with neurological,
ocular, skeletal, and other abnormalities,1 the genetic basis
remains unclear. Recently, mutations in the LAMB2 gene
were described by Zenker et al.8,9 as a cause underlying
Pierson syndrome (microcoria-congenital nephrosis syn-
drome; OMIM #609049), denoting an entity characterized
by congenital nephrotic syndrome and a complex ocular
maldevelopment with non-reactive narrowing of the pupils
(microcoria) as the prominent clinical finding.10 Herein, we
report for the first time on LAMB2 mutations in patients
with much milder disease, based on the initial observation of
linkage to the LAMB2 locus in a consanguineous family
(F1012) with isolated congenital nephrotic syndrome. The
findings emphasize that LAMB2 mutations should be
considered in molecular genetic diagnostics of early onset
nephrotic syndrome.
RESULTS
We identified a consanguineous family (F1012) with two
children affected by congenital nephrotic syndrome. Both
developed proteinuria before the age of 3 months and
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end-stage renal failure within the first year of life. Kidney
biopsy of the first child (F1012 II-1) showed focal and
segmental glomerulosclerosis with abnormalities of the
glomerular basement membrane. This girl died of pneumo-
nia after kidney transplantation at the age of 5 years. No
biopsy has been performed in her younger affected brother
(F1012 II-2), who is currently 3 years old. Except for their
renal disease, both children displayed no other primary
abnormalities. Their psychomotor development was normal.
Neurological and ophthalmological investigations, including
ophthalmoscopy revealed no abnormalities in either sibling.
No mutations in NPHS1, NPHS2, and WT1 were found.
Homozygosity mapping of family F1012 yielded four regions
of probable homozygosity by descent. These were confirmed
and refined by typing of polymorphic microsatellite markers,
yielding potential candidate regions on chromosome 3, 4, 10,
and 12 with segments of homozygosity of B12, B1, B37,
and B2 Mb, respectively. The region of interest on chromo-
some 3 (Figure 1) contained LAMB2, the gene encoding
laminin b2, which has been implicated in nephrotic
syndrome in the LAMB2 knockout mouse model as well as
in Pierson syndrome in humans.8,11 Mutational screening of
LAMB2 revealed a homozygous missense mutation
c.737G4A in both affected children (F1012 II-1, II-2). This
mutation predicts a substitution of a highly conserved
arginine residue R246Q (Figure 2; Table 1).
Six additional unrelated families (F797, F1234, F1379,
A141, A816, A931) with one or more children affected by
congenital nephrotic syndrome, who had previously been
tested negative for mutations in NPHS1, NPHS2, and WT1
were subsequently examined by mutational analysis of
LAMB2. There was isolated kidney involvement in five
families and association with nonspecific eye abnormalities
in one. LAMB2 mutations were identified only in family
F1234.
In this family, the first affected child (II-1) was noted to
have congenital nystagmus with a hypopigmented fundus,
strabismus, and myopia. By the age of 3 years, the fundus
hypopigmentation disappeared, whereas high-grade myopia
(diopter 8) persisted with nystagmus and strabismus being
only apparent without corrective lenses. The affected male
sibling (II-2), who was 9 months of age at the last follow-up,
has congenital nephrotic syndrome associated with a
hypopigmented retina, but no nystagmus or refractive error
was evident by that age. Only he was also noted to have mild
narrowing of the pupils. Kidney biopsy of the elder sister (II-
1) showed glomerular minimal lesions with augmentation
and vacuolation of podocytes and broadened lamina rara.
Both children progressed to end-stage renal failure within the
first year of life. Their neurological and cognitive develop-
ment was normal. Both affected children harbored three
heterozygous sequence variations: two nucleotide substitu-
tions c.4140C4A and c.4177C4T, predicting amino-acid
exchanges N1380K and L1393F, respectively, which turned
out to be located on the same, maternally inherited allele, and
one paternally inherited point mutation c.961T4C resulting
in C321R. L1393 and C321 represent highly conserved
residues (Figure 2c).
All changes were not detected in at least 160 matched
control chromosomes from the respective ethnical group
(Turkish or Caucasian).
Figure 1 | Refinement of the LAMB2 gene locus by haplotype
analysis in the consanguineous congenital nephrotic syndrome
family F1012. Thirty-three microsatellite markers on chromosome 3p
are shown on the left from p-ter to cen (top to bottom). Haplotypes
are interpreted in differently shaded bars. Paternal haplotypes are
drawn to the left, maternal ones to the right. The frame depicts the
extent of homozygosity by descent. Physical map positions (Mb) are
given for the flanking markers (underlined) and the candidate gene
LAMB2 (as annotated by GenomeBrowser; http://genome.uscs.edu).
Flanking markers (underlined) are defined through lack of
homozygosity in individuals II:1 and II:2 and delimit a 11.9 Mb
critical genetic interval for this chromosome 3 locus.
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DISCUSSION
LAMB2 mutations were previously found to be consistently
associated with the severe phenotype of Pierson syndrome,
which is characterized by congenital nephrotic syndrome
with diffuse mesangial sclerosis and early onset renal failure,
as well as distinct ocular malformations including micro-
coria, abnormal lens shape with cataracts, and retinal
abnormalities.8–10,12 In addition, children with Pierson
syndrome who survived infancy exhibited severe neurodeve-
lopmental deficits and blindness.8 This report expands the
spectrum of LAMB2-associated disorders to congenital
nephrotic syndrome with milder ocular changes (F1234)
and normal development, and even to isolated congenital
nephrotic syndrome (F1012). Ocular abnormalities in family
F1234 included myopia, fundus abnormality, and nystagmus,
whereas pupillary anomalies, previously regarded as the
hallmark of Pierson syndrome, were only mildly present in
one of the two affected children (II-1). None of the patients
reported here had cataracts or severe impairment of visual
function as seen in Pierson syndrome. Remarkably, the
Figure 2 | Position of mutations in the LAMB2 gene. (a) Exon–intron structure of LAMB2 showing the position of previously published
mutations in Pierson syndrome above the gene. Truncating mutations are shown in red; missense mutations in green. (b) Four different
missense variants were detected in two families with congenital nephrotic syndrome (see also Table 1). Sequence traces are shown for affected
individuals (top) and healthy controls (bottom). The R246Q mutation was present in individuals F1012 II-1 and II-2 in the homozygous state,
whereas the C321R, N1380K, and L1393F sequence variants were present in patients F1234 II-1 and II-2 in the heterozygous state. (c) Alignment
of LAMB2 sequences with lower organisms shows a high level of evolutionary conservation of mutated residues. For sequence variant, N1380K
alignment of human homologs LAMB2 and LAMB1 shows substitution of N1380 by K1380.
Table 1 | LAMB2 mutations and clinical presentation in two unrelated families with congenital nephrotic syndrome
Family (individual)
Ethnic
origin
Nucleotide
alteration(s)a
Alteration(s) in
coding sequence
Exon
(segregation)b
Parental
consan guinity
Onset of
congenital
nephrotic
syndrome
Extrarenal
manifestation
F1012 (II-1) (II-2) Turkish c.737G4A R246Q 7 (hom, M, P) + 1 month None
c.737G4A R246Q 7 (hom, M, P) after birth None
F1234 (II-1) (II-2) German-
Caucasian
c.961T4C
c.4140C4A and
c.4177C4T
C321R
N1380K and
L1393F
8 (het, P)
26 and 26 (het,
M)
 3 months Nystagmus,
myopia,
strabismus
c.961T4C
c.4140C4A and
c.4177C4T
C321R
N1380K and
L1393F
8 (het, P)
26 and 26 (het,
M)
After birth Hypopigmented
retina
aAll mutations were absent from at least 160 healthy control subjects.
bHet, heterozygous in affected individual; hom, homozygous in affected individual; M, mutation identified in mother; P, mutation identified in father.
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association of congenital nephrotic syndrome and nystagmus
with retinal abnormalities was reported previously as a
distinct entity,13 listed in the OMIM database as ‘mesangial
sclerosis, diffuse renal, with ocular abnormalities’ (OMIM
#249660). Presence of nystagmus has also been reported
occasionally in other patient cohorts with congenital
nephrotic syndrome.1,14 The patients presented here also
had a slower progression to renal failure and less severe
changes on kidney biopsies compared to Pierson syndrome.
Our findings suggest that this condition might represent a
milder allelic variant of Pierson syndrome.
This view is supported by the strong predominance of
biallelic-truncating LAMB2 mutations with complete lack of
laminin b2 in patients with the typical Pierson phenotype,8,9
in contrast to the missense changes demonstrated here, that
may represent hypomorphic alleles. Only two previously
reported siblings15 had a missense mutation of LAMB2
(R246W), and they also displayed a somewhat milder clinical
course in that they did not experience end-stage renal failure
before the age of 6 months. Residual laminin b2 expression
was shown in kidney tissue of one of these children.8
Although no functional studies have been performed, the
amino-acid changes R246Q, C321R, and L1393F are very
likely to be causative mutations, based on formal criteria
(evolutionary conservation, absence in healthy controls,
segregation of the mutations with the phenotype). R246Q
affects the same highly conserved residue as the R246W
mutation that has been reported to cause Pierson syndrome
and be associated with markedly reduced expression of
LAMB2.8 R246 is located within the N-terminal domain VI,
which mediates the polymerization of laminin heterotri-
mers.16 We speculate that substitution of this residue
perturbs this process to varying degrees, depending on the
nature of the mutant residue at this position, with
tryptophan having a more deleterious effect than glutamine.
C321, which belongs to the first of 13 laminin-type epidermal
growth factor-like motifs of the laminin b2 protein is
likely involved in an intramolecular disulfide bond with
C312 (Swiss-Prot: locus LAMB2_HUMAN, accession no.
P55268). Moreover, substitution of the corresponding
amino acid, C293, in the human paralog laminin b3 has
been identified as a cause of junctional epidermolysis
bullosa.17 L1393 is located within domain II, which is
particularly rich in hydrophobic side chains and forms a
coiled-coil structure to which all three chains of the
cross-shaped laminin heterotrimer contribute. Mutation
of this residue may perturb the assembly of the triple
helical structure of laminin heterotrimers. L1393F is more
likely than N1380K to be the causative maternal mutation in
family F1234 as N1380 is substituted by K1380 in human
LAMB1.
The clinical and molecular findings presented here clearly
indicate genotype–phenotype correlations among patients
with LAMB2 mutations: homozygosity or compound hetero-
zygosity for mutations conferring complete loss-of-function
(e.g. truncating mutations) appear to be consistently
associated with the typical features of Pierson syndrome,
including neonatal renal failure, severe ocular abnormalities,
and neurological impairment in long-term survivors. In
contrast, patients with non-truncating (missense) LAMB2
mutations may display variable phenotypes ranging from a
milder variant of Pierson syndrome (as observed with the
R246W mutation) to isolated congenital nephrotic syndrome
(as reported herein with the R246Q mutation). A syndrome
comprising congenital nephrotic syndrome and ocular
anomalies with nystagmus and nonspecific fundus irregula-
rities (OMIM #249660) may represent an intermediate
phenotype among the b2 lamininopathies. We conclude that
LAMB2 mutational screening should be considered in any
case of congenital nephrotic syndrome, particularly in the
presence of ocular abnormalities of any kind, but also in
isolated congenital nephrotic syndrome if no mutations have
been found in NPHS1, NPHS2, or WT1.
MATERIALS AND METHODS
We obtained blood samples for DNA extraction and clinical data
following informed parental consent. Ethics committee approval
was obtained from the ethics committee of the University of
Freiburg (Freiburg, Germany) and the Internal Review Board of the
University of Michigan (IRBMED, Ann Arbor, MI, USA). The
clinical diagnosis of congenital nephrotic syndrome was established
by nephrologists from different pediatric nephrology centers
according to published criteria.18 For clinical evaluation, we used
a standard questionnaire as described previously.19 All patients
included in this study were specifically examined by ophthalmo-
logists. In addition, neurological status, cognitive function, and
development were documented according to the regular German
screening program in standardized clinical examinations at 0.25, 0.5,
1, 2, 4, and 6 years of age.
Whole genome linkage scans were performed using a 10K single
nucleotide polymorphism hybridization array (Affymetrix, Santa
Clara, CA, USA). Multipoint lod scores were calculated using the
Genehunter program v2.1_r3.20 Further genotyping was achieved by
analyzing polymorphic microsatellites markers generated from the
public human genome sequence. Markers were analyzed on an ABI
Prisms 3100-Avant Genetic Analyzer (Applied Biosystems, Foster
City, CA, USA). Primer sequences are available on request.
Mutational analysis of LAMB2 was performed by bidirectional
sequencing of all 32 exons of the gene including the flanking
intronic regions as described previously.8
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We retrieved the sequence and exon–intron boundaries of the LAMB2
gene from the University of California, Santa Cruz (http://genome.
uscs.edu/ Freeze May 2004).
NOTES
In the meantime, both patients of family F1234 have developed
severe unilateral retinal detachment.
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